OncoTherapy Science, Inc.JP:4564Cash flow

Market cap
¥6.7B
P/E ratio
2015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Depreciation & amortization10612690149392404917---
Cash from operations -1,703-2,898-2,988-3,036-2,373-2,276-1,763-2,073-795-1,228-815
Capital expenditures-46-112-11-409-71-131-44-457-5-3-0
Cash from investing 1,88410,883-12-446-74-31-52-468-20-33-0
Cash from financing 681221515662,164-1,479966711,122